Katherine Knudsen

Katherine Knudsen, Ph.D. has a diverse work experience in the field of scientific research and development. Katherine is currently a Product Development Scientist at Biofidelity, where they began their role in January 2023. Prior to this, from February 2022 to December 2022, they worked as a Senior Scientist, Biopharma Platform at xilis.

Before joining xilis, Katherine held multiple positions at Q² Solutions. Katherine served as a Senior Scientist II, Assay Development from November 2020 to March 2022, and as a Senior Scientist I, Assay Development from August 2018 to November 2020.

Their earlier experiences include working as a Graduate Research Assistant at North Carolina State University from July 2012 to August 2018. Throughout their career, Katherine has established a strong foundation in scientific research and development, with a focus on assay development and biopharma platforms.

Katherine Knudsen, Ph.D. pursued their education in the field of Genetics and Molecular Biotechnology. Katherine obtained their Doctor of Philosophy (Ph.D.) degree from North Carolina State University, studying Genetics and completing a minor in Molecular Biotechnology. Katherine started their doctoral program in 2012 and successfully completed it in 2018.

Prior to their Ph.D., Katherine Knudsen completed their Bachelor of Science (B.S.) in Molecular, Cellular, and Developmental Biology from North Carolina State University. Katherine also pursued a minor in Genetics during their undergraduate studies and graduated in 2011. However, the specific duration of their bachelor's program is not provided.